{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:35:50Z","timestamp":1781195750707,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Involvement of the intestinal autonomic nerves in Guillain-Barr\u00e9 syndrome (GBS) can lead to paralytic ileus, a condition commonly observed in severe cases during later stages of the disease. Cases with paralytic ileus as a presenting symptom are very rare. We report a case of a 35-year-old male patient who was admitted to the hospital with acute abdominal pain persisting for 12 hours. Abdominal CT suggested small bowel obstruction, for which routine conventional pharmacological treatment were ineffective. Subsequently, the patient presented with multiple sets of cranial nerve paralysis, bilateral symmetrical delayed paralysis, distal limb numbness, respiratory failure, urinary retention, shock, and electrophysiology, suggesting axonal-type multifocal peripheral nerve damage. Notably, blood antiganglioside tests showed IgG positivity for anti-sulfatide antibodies, anti-GD1a antibodies, and anti-GT1a antibodies. The patient was administered plasma exchange combined with intravenous immunoglobulin, and symptoms gradually improved. The patient resumed independent ambulation within two months and returned to normal status at one year, with no recurrence of symptoms. Given that paralytic ileus can precede other neurological abnormalities in patients with GBS, early detection and individualized treatment are critical to reduce the risk of death and promote recovery. Here, we demonstrate that intensive immunotherapy is a viable therapeutic approach that can be clinically adopted for such conditions.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1435817","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T07:06:47Z","timestamp":1743577607000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Successful treatment of severe Guillain-Barr\u00e9 syndrome with paralytic ileus as a presenting symptom by intensive immunotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Long","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00517-1","article-title":"Guillain-barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-018-0542-y","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update","volume":"29","author":"Zaeem","year":"2019","journal-title":"Clin Auton Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0783-0","article-title":"Paralytic ileus as a presenting symptom of Guillain-Barr\u00e9 syndrome","volume":"255","author":"Nowe","year":"2008","journal-title":"J Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in guillain-barr\u00e9 Syndrome: prevalence, clinical spectrum, and outcomes","volume":"32","author":"Chakraborty","year":"2020","journal-title":"Neurocritical Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880171004","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: a review","volume":"17","author":"Zochodne","year":"1994","journal-title":"Muscle Nerve"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322479","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Koike","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(13)70215-1","article-title":"Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies","volume":"12","author":"Kuwabara","year":"2013","journal-title":"Lancet Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16346","article-title":"Guillain-Barr\u00e9 syndrome: History, pathogenesis, treatment, and future directions","volume":"31","author":"Hughes","year":"2024","journal-title":"Eur J Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"Walgaard","year":"2011","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur J Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2022.103070","article-title":"Dysautonomia and related outcomes in Guillain-Barre syndrome","volume":"245","author":"Baz\u00e1n-Rodr\u00edguez","year":"2023","journal-title":"Autonomic Neuroscience: Basic Clin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1095","article-title":"Adynamic ileus in severe Guillain-Barr\u00e9 syndrome","volume":"24","author":"Burns","year":"2001","journal-title":"Muscle Nerve"},{"key":"B14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.44.11.983","article-title":"Autonomic dysfunction in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Tuck","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.10.1885","article-title":"Power spectrum analysis of heart rate variability in Guillain-Barr\u00e9 syndrome. A longitudinal study","volume":"120","author":"Flachenecker","year":"1997","journal-title":"Brain: J Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.3.333","article-title":"Quantitative cardiovascular autonomic function study in Fisher syndrome","volume":"73","author":"Lyu","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/bs.pmbts.2018.03.001","article-title":"Gangliosides in axon stability and regeneration","volume":"156","author":"Lopez","year":"2018","journal-title":"Prog Mol Biol Trans Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3233\/jnd-150078","article-title":"Diagnostic utility of auto antibodies in inflammatory nerve disorders","volume":"2","author":"Emilien","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693005","article-title":"Guillain-barre syndrome","volume":"39","author":"Malek","year":"2019","journal-title":"Semin Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jnr.20395","article-title":"Antiglycolipid antibodies in Guillain-Barr\u00e9 syndrome and related diseases: review of clinical features and antibody specificities","volume":"80","author":"Ariga","year":"2005","journal-title":"J Neurosci Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.009","article-title":"Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment","volume":"281","author":"Campagnolo","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"Cd002063","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","year":"1997","journal-title":"Lancet (London England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain: J Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14898","article-title":"Guillain-Barr\u00e9 syndrome in Eastern China: A study of 595 patients","volume":"28","author":"Song","year":"2021","journal-title":"Eur J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12234","article-title":"Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study","volume":"22","author":"Yamagishi","year":"2017","journal-title":"J Peripher Nerv Syst: JPNS"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(20)30494-4","article-title":"Second intravenous immunoglobulin dose in patients with Guillain-Barr\u00e9 syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial","volume":"20","author":"Walgaard","year":"2021","journal-title":"Lancet Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000007719","article-title":"Current treatment practice of Guillain-Barr\u00e9 syndrome","volume":"93","author":"Verboon","year":"2019","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/08830738221089476","article-title":"Modified zipper method, a promising treatment option in severe pediatric immune-mediated neurologic disorders","volume":"37","author":"Nikolaus","year":"2022","journal-title":"J Child Neurol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2017.03.048","article-title":"Optimizing the electrodiagnostic accuracy in Guillain-Barr\u00e9 syndrome subtypes: Criteria sets and sparse linear discriminant analysis","volume":"128","author":"Uncini","year":"2017","journal-title":"Clin neurophysiology: Off J Int Fed Clin Neurophysiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519893169","article-title":"Paralytic ileus as the presenting symptom for Guillain-Barr\u00e9 syndrome: a case report","volume":"48","author":"Lee","year":"2020","journal-title":"J Int Med Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-205155","article-title":"Intestinal pseudo-obstruction as a presenting symptom of Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Man","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000030434","article-title":"Paralytic ileus as first symptom of Miller Fisher syndrome: A case report","volume":"101","author":"Liu","year":"2022","journal-title":"Medicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1435817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T07:06:51Z","timestamp":1743577611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1435817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2025.1435817"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1435817","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"article-number":"1435817"}}